No Picture

Successful IsoRay Study of Cesium-131 Internal Radiation Therapy for Breast Cancer Paves the Way for Advanced Treatment

RICHLAND, Wash.–(BUSINESS WIRE)–IsoRay, Inc. (Amex: ISR) announced, today, it has completed an initial feasibility study, which demonstrates the ability to use its patented Cesium-131 (Cs-131) brachytherapy seeds (internal radiation therapy) in accelerated partial breast irradiation […]